Advertisement

Neurochemistry and Pharmacology of Addictions: An African Perspective

  • Andrew G. MtewaEmail author
  • Serawit Deyno
  • Emmanuel L. Peter
  • Annu Amanjot
  • Lucrèce Y. Ahovegbe
  • Duncan C. Sesaazi
Chapter

Abstract

The aim of this chapter is to outline general chemical and pharmacological mechanisms involved in addictions, African participation in neuroscience research and studies as well as challenges and opportunities in the continent. African indigenous practices are known from history to be able to use herbs to counter addictions at various levels. There is generally limited data on this area of study on Africa, where addictions are almost ignored as a public health concern. Despite this being the case, Africa presents a pool of opportunities in research on neurochemisty with focus on addictions. Chemistry and pharmacology can play a significant role in providing guidance on appropriate social and medical interventions. Systematic investment in neurochemistry and pharmacology in addiction research and training in Africa is required across the continent.

References

  1. Akinyemi, A.J., G. Oboh, O. Ogunsuyi, A.O. Abolaji, and A. Udofia. 2018. Curcumin-Supplemented Diets Improve Antioxidant Enzymes and Alter Acetylcholinesterase Genes Expression Level in Drosophila Melanogaster Model. Metabolic Brain Disease 33: 369–375.CrossRefGoogle Scholar
  2. Alper, K.R., H.S. Lotsof, and C.D. Kaplan. 2008. The Ibogaine Medical Subculture. Journal of Ethnopharmacology 115: 9–24.CrossRefGoogle Scholar
  3. Awenva, A.D., U.M. Read, A.L. Ofori-Attah, V.C. Doku, B. Akpalu, A.O. Osei, and A.J. Flisher. 2010. From Mental Health Policy Development in Ghana to Implementation: What Are the Barriers? The African Journal of Psychiatry 13: 184–191.Google Scholar
  4. Beaumont, A. 1983. Putative Peptide Neurotransmitters: The Opioid Peptides. International Review of Experimental Pathology 25: 279–305.PubMedGoogle Scholar
  5. Bettinardi-Angres, K., and D.H. Angres. 2010. Understanding the Disease of Addiction. Journal of Nursing Regulation 1 (2): 31–37.CrossRefGoogle Scholar
  6. Blanckenberg, J., S. Bardien, B. Glanzmann, N.U. Okubadejo, and J.A. Carr. 2013. The Prevalence and Genetics of Parkinson’s Disease in Sub-Saharan Africans. Journal of the Neurological Sciences 335: 22–25.CrossRefGoogle Scholar
  7. Brookshire, B. 2013. Dopamine Is ____. Is it love? Gambling? Reward? Addiction? [Online]. Available: http://www.slate.com/articles/health_and_science/science/2013/07/what_is_dopamine_love_lust_sex_addiction_gambling_motivation_reward.html. Accessed 7 Jun 2018.
  8. Bubar, M.J., and K.A. Cunningham. 2008. Prospects for Serotonin 5-HT2R Pharmacotherapy in Psychostimulant Abuse. Progress in Brain Research 172: 319–346.CrossRefGoogle Scholar
  9. Chitwood, D.D., M.L. Weiss, and C.G. Leukefeld. 2008. A Systematic Review of Recent Literature on Religiosity and Substance Use. Journal of Drug Issues 38: 649–652.CrossRefGoogle Scholar
  10. Collins, P., D.J. Stein, A. Pretorius, H. Sinclair, D. Ross, G. Barr, A. Hofmeyr, C. Sharp, D. Spurrett, J. Rousseau, G. Ainslie, A. Dellis, H. Kincaid, and N. Bak. 2011. Addressing Problem Gambling: South Africa’s National Responsible Gambling Programme. South African Medical Journal 101: 722–723.PubMedGoogle Scholar
  11. Elhadi, A.M., S. Kalb, L. Perez-Orribo, A.S. Little, R.F. Spetzler, and M.C. Preul. 2012. The Journey of Discovering Skull Base Anatomy in Ancient Egypt and the Special Influence of Alexandria. Neurosurgical Focus 33 (2): E2.CrossRefGoogle Scholar
  12. El-Khamlichi, A. 1996. African Neurosurgery. 1: Historical Outline. Neuro-Chirurgie 42: 312–320.PubMedGoogle Scholar
  13. Everitt, B.J., and T.W. Robbins. 2005. Neural Systems of Reinforcement for Drug Addiction: From Actions to Habits to Compulsion. Nature Neuroscience 8: 1481–1489.CrossRefGoogle Scholar
  14. Ewan, E.E., and T.J. Martin. 2011. Rewarding Electrical Brain Stimulation in Rats After Peripheral Nerve Injury: Decreased Facilitation by Commonly Abused Prescription Opioids. Anesthesiology 115: 1271–1280.PubMedPubMedCentralGoogle Scholar
  15. Forray, A., and M. Sofuoglu. 2014. Future Pharmacological Treatments for Substance Use Disorders. British Journal of Clinical Pharmacology 77: 382–400.CrossRefGoogle Scholar
  16. Fresquez-Chavez, K.R., and S. Fogger. 2015. Reduction of Opiate Withdrawal Symptoms With Use of Clonidine in a County Jail. Journal of Correctional Health Care 21: 27–34.CrossRefGoogle Scholar
  17. George-Carey, R., D. Adeloye, K.Y. Chan, A. Paul, I. Kolcić, H. Campbell, and I. Rudan. 2012. An Estimate of the Prevalence of Dementia in Africa: A Systematic Analysis. Journal of Global Health 2: 1–13.CrossRefGoogle Scholar
  18. Gibbons, F.X., M. Gerrard, M.J. Cleveland, T.A. Wills, and G. Brody. 2004. Perceived Discrimination and Substance Use in African American Parents and Their Children: A Panel Study. Journal of Personality and Social Psychology 86: 517.CrossRefGoogle Scholar
  19. Gnegy, M.E. 2012. Catecholamines A2. In Basic Neurochemistry, ed. G.J. Siegel, R.W. Albers, and D.L. Price, 8th ed. New York: Academic Press.Google Scholar
  20. González, J., J.P. Prieto, P. Rodríguez, M. Cavelli, L. Benedetto, A. Mondino, M. Pazos, G. Seoane, I. Carrera, C. Scorza, and P. Torterolo. 2018. Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile. Frontiers in Pharmacology 9: 1–11.CrossRefGoogle Scholar
  21. Guarnotta, E. 2018. A Guide to Addiction and Recovery for African Americans. The Right Addiction Recovery Center.Google Scholar
  22. Hodge, D.R., P. Cardenas, and H. Montoya. 2001. Substance Use: Spirituality and Religious Participation as Protective Factors Among Rural Youths. Social Work Research 25: 153–160.CrossRefGoogle Scholar
  23. Howells, F.M., and J.S. Womersley. 2018. Progress in Neuroscience in Africa: Editorial. Metabolic Brain Disease 33: 357–358.CrossRefGoogle Scholar
  24. Jorgensen, H.S. 2007. Studies on the Neuroendocrine Role of Serotonin. Danish Medical Bulletin 54: 266–288.PubMedGoogle Scholar
  25. Karikari, T.K., and J. Aleksic. 2015. Neurogenomics: An Opportunity to Integrate Neuroscience, Genomics and Bioinformatics Research in Africa. Applied & Translational Genomics 5: 3–10.CrossRefGoogle Scholar
  26. Karikari, T.K., N.A. Yawson, and E. Quansah. 2016. Developing Science Communication in Africa: Undergraduate and Graduate Students Should be Trained and Actively Involved in Outreach Activity Development and Implementation. Journal of Undergraduate Neuroscience Education 14: E5–E8.PubMedPubMedCentralGoogle Scholar
  27. Kitajima, M., M. Iwai, R. Kikura-Hanajiri, Y. Goda, M. Iida, H. Yabushita, and H. Takayama. 2011. Discovery of Indole Alkaloids with Cannabinoid CB1 Receptor Antagonistic Activity. Bioorganic & Medicinal Chemistry Letters 21: 1962–1964.CrossRefGoogle Scholar
  28. Kries, H., and S.E. O’Connor. 2016. Biocatalysts from Alkaloid Producing Plants. Current Opinion in Chemical Biology 31: 22–30.CrossRefGoogle Scholar
  29. Lavaud, C., and G. Massiot. 2017. The Iboga Alkaloids. In Progress in the Chemistry of Organic Natural Products, ed. A. Kinghorn, H. Falk, S. Gibbons, and J. Kobayashi. Cham: Springer.Google Scholar
  30. Lewis, M.D. 2011. Dopamine and the Neural “Now”: Essay and Review of Addiction: A Disorder of Choice. Perspectives on Psychological Science 6: 150–155.CrossRefGoogle Scholar
  31. Mattis, J.S., and R.J. Jagers. 2001. A Relational Framework for the Study of Religiosity and Spirituality in the Lives of African Americans. Journal of Community Psychology 29: 519–539.CrossRefGoogle Scholar
  32. Mosberg, H.I., R.C. Haaseth, K. Ramalingam, A. Mansour, H. Akil, and R.W. Woodard. 1988. Role of Steric Interactions in the Delta Opioid Receptor Selectivity of [D-Pen2, D-Pen5]Enkephalin. International Journal of Peptide and Protein Research 32: 1–8.CrossRefGoogle Scholar
  33. Muller, C.P., and J.R. Homberg. 2015. The Role of Serotonin in Drug Use and Addiction. Behavioural Brain Research 277: 146–192.CrossRefGoogle Scholar
  34. Nestler, E.J. 2013. Cellular Basis of Memory for Addiction. Dialogues in Clinical Neuroscience 15: 431–443.PubMedPubMedCentralGoogle Scholar
  35. Nutt, D.J., A. Lingford-Hughes, D. Erritzoe, and P.R. Stokes. 2015. The Dopamine Theory of Addiction: 40 Years of Highs and Lows. Nature Reviews. Neuroscience 16: 305–312.CrossRefGoogle Scholar
  36. Ozaki, M. 2016. Characteristics and Functional Roles of Opioids Originally Present in Vivo. Yakugaku Zasshi 136: 591–605.CrossRefGoogle Scholar
  37. Perry, E.C. 2014. Inpatient Management of Acute Alcohol Withdrawal Syndrome. CNS Drugs 28: 401–410.CrossRefGoogle Scholar
  38. Piper, M.E. 2015. Withdrawal: Expanding a Key Addiction Construct. Nicotine & Tobacco Research 17: 1405–1415.CrossRefGoogle Scholar
  39. Quansah, E., and T.K. Karikari. 2016. Neuroscience-Related Research in Ghana: A Systematic Evaluation of Direction and Capacity. Metabolic Brain Disease 31: 11–24.CrossRefGoogle Scholar
  40. Qureshi, M.M., and D. Oluoch-Olunya. 2010. History of Neurosurgery in Kenya, East Africa. World Neurosurgery 73: 261–263.CrossRefGoogle Scholar
  41. Ren, L.Q., M. Chen, H. Hultborn, S. Guo, Y. Zhang, and M. Zhang. 2017. Heterogenic Distribution of Aromatic L-Amino Acid Decarboxylase Neurons in the Rat Spinal Cord. Frontiers in Integrative Neuroscience 11 (31): 1–19.Google Scholar
  42. Robertson, J.R., and A.M. Daniels. 2012. Methadone Replacement Therapy: Tried, Tested, Effective? The Journal of the Royal College of Physicians of Edinburgh 42: 133–138.CrossRefGoogle Scholar
  43. Rote, S.M., and B. Starks. 2010. Racial/Ethnic Differences in Religiosity and Drug Use. Journal of Drug Issues 10: 729–754.Google Scholar
  44. Rush, R.A., and L.B. Geffen. 1980. Dopamine Beta-Hydroxylase in Health and Disease. Critical Reviews in Clinical Laboratory Sciences 12: 241–277.CrossRefGoogle Scholar
  45. Russell, V.A. 2017. Notes on the Recent History of Neuroscience in Africa. Frontiers in Neuroanatomy 11: 1–8.CrossRefGoogle Scholar
  46. Schenberg, E.E., M.A.C. Comis, B.R. Chaves, and D.X. Da-Silveira. 2014. Treating Drug Dependence with the Aid of Ibogaine: A Retrospective Study. Journal of Psychopharmacology 28: 993–1000.CrossRefGoogle Scholar
  47. Sevenzo, F. 2015. Drug Addiction in Africa. The Africa Report, 20 May 2015.Google Scholar
  48. Small, D.M., M. Jones-Gotman, and A. Dagher. 2003. Feeding-Induced Dopamine Release in Dorsal Striatum Correlates with Meal Pleasantness Ratings in Healthy Human Volunteers. NeuroImage 19: 1709–1715.CrossRefGoogle Scholar
  49. Stead, L.F., R. Perera, C. Bullen, D. Mant, J. Hartmann-Boyce, K. Cahill, and T. Lancaster. 2012. Nicotine Replacement Therapy for Smoking Cessation. Cochrane Database of Systematic Reviews 14: 11.Google Scholar
  50. Stein, D.J. 2015. Academic-Industry Partnerships in Alcohol and Gambling: A Continuum of Benefits and Harms. Israeli Journal of Psychiatry and Related Sciences 52: 81–84.Google Scholar
  51. Tomkins, D.M., and E.M. Sellers. 2001. Addiction and the Brain: The Role of Neurotransmitters in the Cause and Treatment of Drug Dependence. CMAJ 164: 817–821.PubMedPubMedCentralGoogle Scholar
  52. UNODC. 2004. Conducting Effective Substance Abuse Prevention Work Among the Youth in South Africa. Pretoria: United Nations Office on Drugs and Crime.Google Scholar
  53. URT. 2013. Standard Treatment Guidelines and Essential Medicines List. Dar-es-salaam: Ministry of Health and Social Welfare, The United Republic of Tanzania.Google Scholar
  54. Van-Niekerk, J.P. 2011. Addiction. South African Medical Journal 101: 673.CrossRefGoogle Scholar
  55. Volkow, N.D., G.J. Wang, J.S. Fowler, and D. Tomasi. 2012. Addiction Circuitry in the Human Brain. Annual Review of Pharmacology and Toxicology 52: 321–336.CrossRefGoogle Scholar
  56. Wallace, J.M., and J.R. Muroff. 2002. Preventing Substance Abuse Among African American Children and Youth: Race Differences in Risk Factor Exposure and Vulnerability. The Journal of Primary Prevention 22: 235–261.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Andrew G. Mtewa
    • 1
    • 3
    Email author
  • Serawit Deyno
    • 3
  • Emmanuel L. Peter
    • 2
    • 3
  • Annu Amanjot
    • 3
  • Lucrèce Y. Ahovegbe
    • 3
  • Duncan C. Sesaazi
    • 3
  1. 1.Malawi University of Science and TechnologyBlantyreMalawi
  2. 2.National Institute for Medical Research (NIMR)Dar es SalaamTanzania
  3. 3.PHARMBIOTRACMbarara University of Science and TechnologyMbararaUganda

Personalised recommendations